<DOC>
	<DOC>NCT02860585</DOC>
	<brief_summary>The objective of this study was to evaluate the outcome of patients affected with different subtypes of metastatic breast cancer following treatment with high-dose chemotherapy and autologous haematopoietic progenitor cell transplantation.</brief_summary>
	<brief_title>Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age&gt;18 years Metastatic breast Cancer Treatment with highdose chemotherapy and autologous haematopoietic progenitor cell transplantation between 2003 and 2012 Lack of followup data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Metastatic breast cancer</keyword>
	<keyword>high-dose chemotherapy</keyword>
	<keyword>autologous haematopoietic progenitor cell transplantation</keyword>
</DOC>